Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

n-3 Fatty acids, hypertension and risk of cognitive decline among older adults in the Atherosclerosis Risk in Communities (ARIC) study.

Beydoun MA, Kaufman JS, Sloane PD, Heiss G, Ibrahim J.

Public Health Nutr. 2008 Jan;11(1):17-29. Epub 2007 Jul 12.

2.

Plasma n-3 fatty acids and the risk of cognitive decline in older adults: the Atherosclerosis Risk in Communities Study.

Beydoun MA, Kaufman JS, Satia JA, Rosamond W, Folsom AR.

Am J Clin Nutr. 2007 Apr;85(4):1103-11.

3.

Midlife hypertension and 20-year cognitive change: the atherosclerosis risk in communities neurocognitive study.

Gottesman RF, Schneider AL, Albert M, Alonso A, Bandeen-Roche K, Coker L, Coresh J, Knopman D, Power MC, Rawlings A, Sharrett AR, Wruck LM, Mosley TH.

JAMA Neurol. 2014 Oct;71(10):1218-27. doi: 10.1001/jamaneurol.2014.1646.

4.

Associations Between Midlife Vascular Risk Factors and 25-Year Incident Dementia in the Atherosclerosis Risk in Communities (ARIC) Cohort.

Gottesman RF, Albert MS, Alonso A, Coker LH, Coresh J, Davis SM, Deal JA, McKhann GM, Mosley TH, Sharrett AR, Schneider ALC, Windham BG, Wruck LM, Knopman DS.

JAMA Neurol. 2017 Aug 7. doi: 10.1001/jamaneurol.2017.1658. [Epub ahead of print]

PMID:
28783817
5.

Coronary heart disease trends in four United States communities. The Atherosclerosis Risk in Communities (ARIC) study 1987-1996.

Rosamond WD, Folsom AR, Chambless LE, Wang CH; ARIC Investigators. Atherosclerosis Risk in Communities.

Int J Epidemiol. 2001 Oct;30 Suppl 1:S17-22.

PMID:
11759846
6.
7.

Retinal microvascular abnormalities and cognitive impairment in middle-aged persons: the Atherosclerosis Risk in Communities Study.

Wong TY, Klein R, Sharrett AR, Nieto FJ, Boland LL, Couper DJ, Mosley TH, Klein BE, Hubbard LD, Szklo M.

Stroke. 2002 Jun;33(6):1487-92.

8.
9.

Tooth loss, periodontal disease, and cognitive decline in the Atherosclerosis Risk in Communities (ARIC) study.

Naorungroj S, Schoenbach VJ, Wruck L, Mosley TH, Gottesman RF, Alonso A, Heiss G, Beck J, Slade GD.

Community Dent Oral Epidemiol. 2015 Feb;43(1):47-57. doi: 10.1111/cdoe.12128. Epub 2014 Nov 3.

10.

Omega-3 polyunsaturated fatty acid supplements and cognitive decline: Singapore Longitudinal Aging Studies.

Gao Q, Niti M, Feng L, Yap KB, Ng TP.

J Nutr Health Aging. 2011 Jan;15(1):32-5.

PMID:
21267519
11.

Dietary fat intake and carotid artery wall thickness: the Atherosclerosis Risk in Communities (ARIC) Study.

Tell GS, Evans GW, Folsom AR, Shimakawa T, Carpenter MA, Heiss G.

Am J Epidemiol. 1994 May 15;139(10):979-89.

PMID:
8178786
12.

Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study.

Knopman DS, Mosley TH, Catellier DJ, Coker LH; Atherosclerosis Risk in Communities Study Brain MRI Study.

Alzheimers Dement. 2009 May;5(3):207-14. doi: 10.1016/j.jalz.2009.01.027. Epub 2009 Apr 11.

PMID:
19362884
13.

Cerebral MRI findings and cognitive functioning: the Atherosclerosis Risk in Communities study.

Mosley TH Jr, Knopman DS, Catellier DJ, Bryan N, Hutchinson RG, Grothues CA, Folsom AR, Cooper LS, Burke GL, Liao D, Szklo M.

Neurology. 2005 Jun 28;64(12):2056-62.

PMID:
15985571
14.

Dietary antioxidant intake and cognitive performance in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study investigators.

Peacock JM, Folsom AR, Knopman DS, Mosley TH, Goff DC Jr, Szklo M.

Public Health Nutr. 2000 Sep;3(3):337-43.

PMID:
10980106
15.

Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest.

Siscovick DS, Raghunathan TE, King I, Weinmann S, Wicklund KG, Albright J, Bovbjerg V, Arbogast P, Smith H, Kushi LH, et al.

JAMA. 1995 Nov 1;274(17):1363-7.

PMID:
7563561
16.

Dietary fatty acids and peripheral artery disease in adults.

Naqvi AZ, Davis RB, Mukamal KJ.

Atherosclerosis. 2012 Jun;222(2):545-50. doi: 10.1016/j.atherosclerosis.2012.03.029. Epub 2012 Apr 7.

17.
18.

Association of hospitalization with long-term cognitive and brain MRI changes in the ARIC cohort.

Brown CH 4th, Sharrett AR, Coresh J, Schneider AL, Alonso A, Knopman DS, Mosley TH, Gottesman RF.

Neurology. 2015 Apr 7;84(14):1443-53. doi: 10.1212/WNL.0000000000001439. Epub 2015 Mar 11.

19.

Neighbourhood differences in diet: the Atherosclerosis Risk in Communities (ARIC) Study.

Diez-Roux AV, Nieto FJ, Caulfield L, Tyroler HA, Watson RL, Szklo M.

J Epidemiol Community Health. 1999 Jan;53(1):55-63.

20.

Effects of basal insulin glargine and omega-3 fatty acid on cognitive decline and probable cognitive impairment in people with dysglycaemia: a substudy of the ORIGIN trial.

Cukierman-Yaffe T, Bosch J, Diaz R, Dyal L, Hancu N, Hildebrandt P, Lanas F, Lewis BS, Marre M, Yale JF, Yusuf S, Gerstein HC; ORIGIN Investigators.

Lancet Diabetes Endocrinol. 2014 Jul;2(7):562-72. doi: 10.1016/S2213-8587(14)70062-2. Epub 2014 Jun 2.

PMID:
24898834

Supplemental Content

Support Center